Collaboration - March 17, 2021
Antibiotic resistance – a silent threat
The Nordic Council Welfare Committee has just concluded a webinar debate with members of the European parliament, researchers and industry figures about antibiotic resistance. The significant and ongoing increase in the use of antibiotics has led to a growing global problem in the form of antibiotic-resistant bacteria. COVID-19 and its effects further underline the importance […]
Collaboration - March 12, 2021
Unique business opportunities at NLSDays Digital
The 2021 NLSDays, April 20-23, will be arranged digitally and will include extended time for face-to-face partnering meetings, high-level content sessions, workshops and innovating digital networking features. Since its inception in 2013, Nordic Life Science Days (NLSDays) has grown to become the largest Nordic partnering conference dedicated to the life science industry. This annual event […]
Collaboration - March 9, 2021
Aptamer Group extends collaboration with AstraZeneca
This agreement will build upon the existing collaboration to evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates. Optimers are optimized aptamer reagents. Based on oligonucleotide molecules Optimers can bind specifically to a target molecule to act as an antibody alternative. […]
Biotech Business - March 8, 2021
ISD Immunotech enters strategic research collaboration
ISD Immunotech has entered into a strategic research collaboration with Biogen. ISD and Biogen will work together to develop ISD’s lead compound, ISD 017, which is being developed to treat severe lupus – systemic lupus erythematosus (SLE). ISD 017 is a peptide therapeutic which is an inhibitor of the stimulator of interferon genes (STING) pathway. […]
Collaboration - March 5, 2021
Oasmia enters collaboration with Karolinska Institutet
The collaboration will generate new information aiming at the development of new therapeutic APIs. The XR-17 platform technology enhances intravenous delivery of established and novel drugs in diseases including cancer, according to Oasmia. The collaboration will include a review of data and experimental methods to gain a deeper understanding of XR-17 and API formulations in […]
Collaboration - February 24, 2021
Novo Nordisk and the University of Toronto announce joint investment
The DKK 200 million investment will be used to establish the Novo Nordisk Network for Healthy Populations. The network will focus on new ways to support healthier urban populations and will draw on U of T’s expertise in public health research and education programmes to impact the global fight against diabetes and other serious chronic […]
